Drug application
NITROFURANTOIN MACROCRYSTALLINE (NITROFURANTOIN, MACROCRYSTALLINE)
Drugs@FDA ANDA 070249 · WATSON LABS
Key facts
| Drug name | NITROFURANTOIN MACROCRYSTALLINE |
|---|---|
| Active ingredients | NITROFURANTOIN, MACROCRYSTALLINE |
| Application type | ANDA |
| Application number | 070249 |
| Company | WATSON LABS |
| Dosage forms | CAPSULE, ORAL |
| Strength | 100MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
At a glance
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.